Pharmaceuticals(IN40264.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Pharmaceuticals
IN40264.SH
News
View More

CSPC Innovation Pharmaceutical Reports Full-Year Net Loss for 2025

CSPC Innovation Pharmaceutical, a subsidiary of CSPC Pharmaceutical Group, reported a significant net loss for the year 2025. This information was originally published by CSPC Pharmaceutical Group Ltd. via the Hong Kong Stock Exchange on January 15, 2026. The news brief is generated by Public Technologies and is for informational purposes only, not to be considered as financial or legal advice.

Reuters·
SZ
300765
-4.95%
Reuters·
SZ
300765
-4.95%

New World Group personnel changes, K11 Hotels clarifies that the group and brand will not be sold, New World stock price once rose over 15%

The news that Zheng Jiachun, Chairman of New World (017), is exploring the sale of some assets of the Rosewood Hotel Group has attracted market attention. The Rosewood Hotel Group clarified that it will not sell and that all hotels are operating normally. As a result, New World's stock price fluctuated, rising by more than 15%. At the same time, Xie Huifang, Executive Director and CEO of New World Department Store China (825), has resigned, and Huang Shaomei will take over daily management. The market holds an optimistic attitude towards real estate stocks, with several real estate stocks rising

Stheadline·
SH
600628
-2.15%
Stheadline·
SH
600628
-2.15%

The three major A-share indices in Shanghai and Shenzhen fell by 0.4% to 1% in the first half of the day, with chip stocks showing weakness and computing power leasing concept stocks giving back gains

The three major A-share indices fell between 0.4% and 1% in the first half of the day, with chip stocks performing weakly. The central parity rate of the RMB against the USD was adjusted to 7.0064, reaching a new high for 2023. The People's Bank of China conducted reverse repurchase operations, with a net injection of 175.3 billion yuan. The performance of domestic bank stocks was mixed, with CITIC Securities showing significant earnings growth. Computing power leasing concept stocks retracted, and SUNFLOWER was placed under investigation for suspected information disclosure violations

AASTOCKS·
SH
600030
+0.18%
HK
06030
-0.83%
SZ
300111
-20.00%
AASTOCKS·
SH
600030
+0.18%
HK
06030
-0.83%
SZ
300111
-20.00%

"Big Banks" Citigroup lists its preferred H-share stocks (Table)

Citi published a strategy report on the Chinese market, listing its preferred H-share stocks: Stock │ Target Price Tencent │ HKD 751 AIA Group │ HKD 99 Hengrui Pharma │ HKD 134 Zijin │ HKD 39 Trip.com │ USD 86 Conant Optical │ HKD 65 Atour │ USD 45 Lens Technology │ HKD 32

AASTOCKS·
US
AAGIY
+0.78%
HK
01299
+0.18%
SH
600276
-0.69%
AASTOCKS·
US
AAGIY
+0.78%
HK
01299
+0.18%
SH
600276
-0.69%

Zhejiang Jingxin Pharmaceutical Directors Grant Nod for Hong Kong Secondary Listing

Zhejiang Jingxin Pharmaceutical Directors Grant Nod for Hong Kong Secondary Listing

marketscreener·
SZ
002020
-0.44%
marketscreener·
SZ
002020
-0.44%
Posts
View More
© 2026 Longbridge｜Disclaimer